NYVEPRIA
NYVEPRIA
Approved
DIN Number
02506238
Drug Class
Human
Market Date
Jan 18, 2021
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02506238
AIG Number0149962001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L03AA13 PEGFILGRASTIM
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PEGFILGRASTIMActive
Strength: 6 MG / 0.6 ML
Monograph: PEGFILGRASTIM